Prognostic Implication of First-Degree Atrioventricular Block in Patients With Hypertrophic Cardiomyopathy

• Published in: Journal of the American Heart Association Vol. 9; no. 6; p. e015064
• Main Authors: Higuchi, Satoshi, Minami, Yuichiro, Shoda, Morio, Shirotani, Shota, Saito, Chihiro, Haruki, Shintaro, Gotou, Masayuki, Yagishita, Daigo, Ejima, Koichiro, Hagiwara, Nobuhisa
• Format: Journal Article
• Language: English
• Published: England John Wiley and Sons Inc 17-03-2020; Wiley
• Subjects: Adult; Aged; Atrioventricular Block - diagnosis; Atrioventricular Block - etiology; Atrioventricular Block - mortality; Atrioventricular Block - therapy; Cardiomyopathy, Hypertrophic - complications; Cardiomyopathy, Hypertrophic - diagnosis; Cardiomyopathy, Hypertrophic - mortality; Cardiomyopathy, Hypertrophic - therapy; Death, Sudden, Cardiac - etiology; Death, Sudden, Cardiac - prevention & control; Female; first‐degree atrioventricular block; Heart Failure - etiology; Heart Failure - mortality; Humans; hypertrophic cardiomyopathy; Longitudinal Studies; Male; Middle Aged; Original Research; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors; risk stratification; Stroke - etiology; Stroke - mortality; sudden cardiac death; Time Factors; hypertrophic cardiomyopathy; risk stratification; sudden cardiac death; first‐degree atrioventricular block
• ISSN: 2047-9980; 2047-9980
• DOI: 10.1161/JAHA.119.015064

Background The association between first-degree atrioventricular block (AVB) and life-threatening cardiac events in patients with hypertrophic cardiomyopathy (HCM) remains unclear. This study sought to investigate whether presence of first-degree AVB was associated with HCM-related death in patients with HCM. Methods and Results We included 414 patients with HCM (mean age, 51±16 years; 64.5% men). The P-R interval was measured at the time of the initial evaluation and patients were classified into those with and without first-degree AVB, which was defined as a P-R interval ≥200 ms. HCM-related death was defined as a combined end point of sudden death or potentially lethal arrhythmic events, heart failure-related death, and stroke-related death. First-degree AVB was noted in 96 patients (23.2%) at time of enrollment. Over a median (interquartile range) follow-up period of 8.8 (4.9-12.9) years, a total of 56 patients (13.5%) experienced HCM-related deaths, including 47 (11.4%) with a combined end point of sudden death or potentially lethal arrhythmic events. In a multivariable analysis that included first-degree AVB and risk factors for life-threatening events, first-degree AVB was independently associated with an HCM-related death (adjusted hazard ratio, 2.41; 95% CI, 1.27-4.58;
=0.007), and this trend also persisted for the combined end point of sudden death or potentially lethal arrhythmic events (adjusted hazard ratio, 2.60; 95% CI, 1.28-5.27;
=0.008). Conclusions In this cohort of patients with HCM, first-degree AVB may be associated with HCM-related death, including the combined end point of sudden death or potentially lethal arrhythmic events.